Logo image
Sex-specific cell signalling: the corticotropin-releasing factor receptor model
Journal article   Open access   Peer reviewed

Sex-specific cell signalling: the corticotropin-releasing factor receptor model

Rita J. Valentino, Elisabeth Van Bockstaele and Debra Bangasser
Trends in pharmacological sciences (Regular ed.), v 34(8), pp 437-444
01 Aug 2013
PMID: 23849813
url
https://europepmc.org/articles/pmc3752157View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology
Elucidating the biological basis for sex differences in diseases can reveal their pathophysiology and guide the development of individualized treatments. Here, we review evidence for the novel concept that receptor signaling can be sex biased such that the specific pathways engaged by ligand binding are determined by sex. As an example, this review focuses on the receptor for corticotropin-releasing factor (CRF), a stress-related peptide implicated in diverse psychiatric and medical disorders that are more prevalent in females. There is evidence for sex biases in CRF receptor coupling to G proteins and beta-arrestin that render females more sensitive to acute stress and less able to adapt to chronic stress. Taken with evidence for sex biased signaling in other receptor systems, the studies demonstrate the broad potential impact of this characteristic in determining sex differences in disease and therapeutic efficacy and underscore the importance of studying females in medical and pharmacological research.

Metrics

4 Record Views
71 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image